Syrris opened an office in La Jolla, California.

Biotage AB elected Axel Broms and Per-Olof Eriksson to its Board, replacing Jeff Bork and Björn Odlander.

In May, Agilent and Integrated DNA Technologies agreed to harmonize their chemistry, processes and analytical techniques and to provide reciprocal referrals for synthetic oligonucleotides, creating a complete development pathway for customers.

Link Technologies licensed the rights from PNA Inventor Group to manufacture and sell peptide nucleic acid (PNA) synthesis.

Panagene licensed the rights to synthesize, manufacture and sell PNA monomers from the Copenhagen Inventor Group, effective June 1.